Utilizing ex vivo and in vivo approaches, we defined a network of RBFOX2-controlled alternative splicing events linked to cytoskeletal remodeling and specifically associated exon-skipping in ABI1 with enhanced migratory potential and enrichment at the cell periphery of pancreatic cancer cells. This evidence concerns the gene RBFOX2 and pancreatic neoplasm.